Aclaris Therapeutics (ACRS) Q4 2022 Earnings

23FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.45
-0.4
-0.35
-0.3

Details

Expected EPS
-0.45
Actual EPS
-0.41
Surprise EPS
0.04
Surprise Percent
+8.89%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.41 per share for Q4 2022.

0 Comments

Share your thoughts